Characterization of potential NMDA and cholecystokinin antagonists II. Lipophilicity studies on 2-methyl-4-oxo-3H-quinazoline-3-alkyl-carboxylic acid derivatives

International Journal of Pharmaceutics

Volumn 180, Issue 1, 1999, Pages 13-22

  Almási, János ^a   Takács Novák, Krisztina ^a   Kökösi, József ^a   Vámos, József ^a  

^a SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

Author keywords

Lipophilicity; Quinazolones; TLC log P determination; True partition coefficient

Indexed keywords

2 METHYL 4 OXO 3H QUINAZOLINE 3 CARBOXYLIC ACID DERIVATIVE; CHOLECYSTOKININ RECEPTOR BLOCKING AGENT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; QUINAZOLINONE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CALIBRATION; DRUG STRUCTURE; IN VITRO STUDY; LIPOPHILICITY; PARTITION COEFFICIENT; PRIORITY JOURNAL; PROTON TRANSPORT; TECHNIQUE; THIN LAYER CHROMATOGRAPHY;

CHOLECYSTOKININ; CHROMATOGRAPHY, THIN LAYER; N-METHYLASPARTATE; QUINAZOLINES;

EID: 0038177635     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(98)00405-0     Document Type: Article

References (23)

1. Almási J., Takács-Novák K., Kökösi J., Noszál B. Characterization of potential NMDA and cholecystokinin antagonists. I. Acid-base properties of 2-methyl-4-oxo-3H-quinazoline-3-alkyl-carboxylic acids at the molecular and submolecular levels. Int. J. Pharm. 180:1999;1-11.
2. Avdeef A. pH-metric logP. 1. Difference plots for determining ion-pair octanol-water partition coefficients of multiprotic substances. Quant. Struct.-Act. Relat. 11:1992;510-517.
3. Avdeef A. pH-metric logP. 2. Refinement of partition coefficients and ionization constants of multiprotic substances. J. Pharm. Sci. 82:1993;183-190.
4. M and logP values. J. Chromatogr. 498:1990;179-190.
5. Bird A.E., Marshall A.C. Reversed-phase thin-layer chromatography and partition coefficients of penicillins. J. Chromatogr. 63:1971;313-319.
6. Colotta V., Catarzi D., Varano F., Cecchi L., Filacchioni G. Synthesis and biological evaluation of a series of quinazoline-2-carboxylic acids and quinazoline-2,4-diones as glycine-NMDA antagonists: a pharmacophore model based approach. Arch. Pharm. 330:1997;129-134.
7. Darwish Y., Cserháti T., Forgács E. Reversed-phase retention characteristics of some bioactive heterocyclic compounds. J. Chromatogr. A. 668:1994;485-494.
8. de Voogt P., van Zijl G.A., Govers H., Brinkman U.A.Th. Reversed-phase TLC and structure-activity relationships of polycyclic (hetero) aromatic hydrocarbons. J. Planar Chromatogr. 3:1990;24-33.
9. Errede A.L., McBrady J.J. Acylanthranils. 7. Influence of the end group on selectivity in the reaction of ω-substituted linear aliphatic amines with acetylanthranil. J. Org. Chem. 43:1978;1884-1887.
10. Hansch C. On the future of QSAR. Wermuth C.G., Koga N., Kõnig H. Medicinal Chemistry for the 21st Century. 1994;281-293 Metcalf Blackwell, Oxford.
11. Hermecz I., Mészáros Z. Chemistry of Pyrido(1,2-a(pyrimidines. Katritzky A.R. Advances in Heterocyclic Chemistry. 33:1983;242-330 Academic Press, New York.
12. Hulshoff A., Perrin J.H. Quantitative correlations between albumin binding constants and chromatographic Rm values of phenothiazine derivatives. J. Med. Chem. 20:1977;430-439.
13. Nagy P., Takács-Novák K. Theoretical and experimental studies of the zwitterion↔neutral form equilibrium of ampholytes in pure solvents and mixtures. J. Am. Chem. Soc. 119:1997;4999-5006.
14. Panderi I., Angelopoulos C., Tsantili-Kakoulidou A., Kazanis M., Vavayannis A. Lipophilicity studies on β-blocker benzoxazinone derivatives. Il Farmaco. 52:1997;167-172.
15. Papp O., Valkó K., Szász Gy., Hermecz I., Vámos J., Hankó K., Ignáth-Halász Zs. Determination of partition coefficients of pyrido[1,2-a]pyrimidin-4-one derivatives by traditional shake, thin-layer chromatographic and gas-liquid chromatographic methods. J. Chromatogr. 252:1982;67-75.
16. Pentassuglia G., Bertani B., Donati D., Ursini A. 1-Phenyl-4(1H)-quinazolinones and 2,3-dihydro-1-phenyl-4(1H)-quinazolinones as potential cholecystokinin receptor ligands. J. Heterocyclic Chem. 33:1996;1163-1170.
17. Takács-Novák, K., 1986. Relationship of the partition coefficient, the protonation constant and the chemical structure within nitrogen bridgehead compounds. Ph.D Thesis, Institute of Pharmaceutical Chemistry, Semmelweis University of Medicine, Budapest, Hungary.
18. Takács-Novák K. Practical aspects of partition measurements according to GLP rules. Acta Pharm. Hung. 67:1997;179-191.
19. Takács-Novák K., Józan M., Hermecz I., Szász Gy. Lipophilicity of antibacterial fluoroquinolones. Int. J. Pharm. 79:1992;89-96.
20. Takács-Novák K., Józan M., Szász Gy. Lipophilicity of amphoteric molecules expressed by the true partition coefficient. Int. J. Pharm. 113:1995;47-55.
21. Tsantili-Kakoulidou A., Antoniadou-Vyza A. Determination of the partition coefficients of adamantyl derivatives by reversed phase TLC and HPLC. Prog. Clin. Biol. Res. 291:1989;71-74.
22. van de Waterbeemd, H., Kansy, M., Wagner, B., Fischer, H., 1996. Lipophilicity measurement by reversed-phase high performance liquid chromatography (RP-HPLC). In: Pliška, V., Testa, B., van de Waterbeemd, H. (Ed.), Methods and Principles in Medicinal Chemistry, Vol. 4, Lipophilicity in Drug Action and Toxicology, VCH, Weinheim, pp. 73-87.
23. Yu M.J., McCowan J.R., Mason N.R., Deeter J.B., Mendelsohn L.G. Synthesis and X-ray crystallographic analysis of quinazolinone cholecystokinin/gastrin receptor ligands. J. Med. Chem. 35:1992;2534-2542.